OPICAPONE'S ADDED BENEFIT AS A FIRST-LINE ADJUNCTIVE THERAPY TO LEVODOPA AND WHEN USED PROMPTLY FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

被引：0
|
作者：
Ebersbach, G. [1 ]
Ferreira, J. J. [2 ]
Antonini, A. [3 ]
Santos, A. [4 ]
Magalhaes, D. [5 ,6 ]
Rocha, J. -F. [5 ]
Soares-da-Silva, P. [4 ,6 ,7 ]
机构：
[1] Beelitz Hosp, Movement Disorders Clin, Beelitz, Germany
[2] Univ Lisbon, Lab Clin Pharmacol & Therapeut, Fac Med, Lisbon, Portugal
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] BIAL Portela & Ca SA, Dept Res & Dev, Coronado, Portugal
[5] BIAL Portela & Ca SA, Med Affairs Dept, Coronado, Portugal
[6] Univ Porto, Porto, Portugal
[7] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 244
引用
收藏
页码：E71 / E72
页数：2
相关论文
共 50 条
  • [41] Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson's disease patients
    Lees, A.
    Rascol, O.
    Ferreira, J.
    Klepitskaya, O.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S461 - S461
  • [42] 1-year safety of opicapone in patients with Parkinson's disease and motor fluctuations
    Lees, A.
    Ferreira, J.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S99 - S99
  • [43] EFFICACY OF OPICAPONE IN DIFFERENT TREATMENT REGIMENS IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS
    Antonini, A.
    Ebersbach, G.
    Rascol, O.
    Ikedo, F.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E64 - E65
  • [44] Antibiotics should be used as first-line therapy for Crohn's disease
    Greenberg, GR
    [J]. INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) : 318 - 320
  • [45] Motor complications of chronic levodopa therapy in Parkinson's disease
    Miyawaki, E
    Lyons, K
    Pahwa, R
    Troster, AI
    Hubble, J
    Smith, D
    Busenbark, K
    McGuire, D
    Michalek, D
    Koller, WC
    [J]. CLINICAL NEUROPHARMACOLOGY, 1997, 20 (06) : 523 - 530
  • [46] Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: Strong study
    Mizuno, Yoshikuni
    Abe, Takashi
    Hasegawa, Kazuko
    Kuno, Sadako
    Kondo, Tomoyoshi
    Yamamoto, Mitsutoshi
    Nakashima, Mitsuyoshi
    Kanazawa, Ichiro
    [J]. MOVEMENT DISORDERS, 2007, 22 (13) : 1860 - 1865
  • [47] Ropinirole versus pergolide as adjunctive therapy to levodopa (LD) in Parkinson's disease
    Unal, Z.
    Boylu, E.
    Orhan, S.
    Deniz, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 247 - 247
  • [48] Rotigotine as adjunctive therapy to levodopa in advanced-stage Parkinson's disease
    Poewe, Werner
    Giladi, Nir
    Boothman, Bernard
    Maguire, Diane
    Boroojerdi, Babak
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S76 - S76
  • [49] Maximizing the benefit:risk ratio of levodopa therapy in Parkinson's disease
    Gottwald, MD
    [J]. PHARMACOTHERAPY, 1999, 19 (11): : 162S - 168S
  • [50] Pramipexole and levodopa impact on the onset of dyskinesias and motor fluctuations in Parkinson's disease
    Subutay-Oztekin, N.
    Oztekin, M. F.
    Sari-Polat, R.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S308 - S308
12345